4//SEC Filing
Nokes Rachael 4
Accession 0000950170-25-018879
CIK 0001604950other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:27 PM ET
Size
7.1 KB
Accession
0000950170-25-018879
Insider Transaction Report
Form 4
Nokes Rachael
CFO and Treasurer
Transactions
- Award
Common Stock
2025-02-11+88,445→ 156,061 total - Award
Stock Option (Right to Buy)
2025-02-11+132,670→ 132,670 totalExercise: $3.34Exp: 2035-02-11→ Common Stock (132,670 underlying)
Footnotes (2)
- [F1]Consists of a restricted stock unit ("RSU") award made pursuant to the scPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2025, such that the RSUs will be fully vested on January 1, 2029.
- [F2]The option shares vest over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2029.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001769138
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:27 PM ET
- Size
- 7.1 KB